BridgeBio Pharma (BBIO) Narrative Is Shifting With Attruby And Late Stage Pipeline
“BridgeBio Pharma is undergoing a significant transformation as Attruby (acoramidis) establishes itself as a leading therapy in transthyretin amyloid cardiomyopathy …